Thrombosis, Venous Risk Profile, Congenital

CPT: 81240; 81241; 85300; 85303; 85306
Print Share

Test Includes

Antithrombin activity; factor II (prothrombin) mutation analysis; factor V Leiden mutation analysis; protein C, functional; protein S antigen, free


Expected Turnaround Time

4 - 10 days


Related Information


Related Documents


Specimen Requirements


Specimen

Plasma, frozen and whole blood or buccal swab kit (Buccal swab collection kit contains instructions for the use of a buccal swab.)


Volume

6 mL frozen plasma (3 mL in each of two tubes) and 7 mL whole blood or LabCorp buccal swab kit


Minimum Volume

3 mL frozen plasma and 3 mL whole blood or two buccal swabs


Container

Blue-top (sodium citrate) tube and lavender-top (EDTA) tube or yellow-top (ACD) tube, or LabCorp buccal swab kit


Collection

Citrated plasma samples should be collected by double centrifugation. Blood should be collected in a blue-top tube containing 3.2% buffered sodium citrate.1 Evacuated collection tubes must be filled to completion to ensure a proper blood-to-anticoagulant ratio.2,3 The sample should be mixed immediately by gentle inversion at least six times to ensure adequate mixing of the anticoagulant with the blood. A discard tube is not required prior to collection of coagulation samples.4,5 When noncitrate tubes are collected for other tests, collect sterile and nonadditive (red-top) tubes prior to citrate (blue-top) tubes. Any tube containing an alternate anticoagulant should be collected after the blue-top tube. Gel-barrier tubes and serum tubes with clot initiators should also be collected after the citrate tubes. Centrifuge for 10 minutes and carefully remove 2/3 of the plasma using a plastic transfer pipette, being careful not to disturb the cells. Deliver to a plastic transport tube, cap, and recentrifuge for 10 minutes. Use a second plastic pipette to remove the plasma, staying clear of the platelets at the bottom of the tube. Transfer the plasma into a LabCorp PP transpak frozen purple tube with screw cap (LabCorp N° 49482). Freeze immediately and maintain frozen until tested. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.

Please print and use the Volume Guide for Coagulation Testing to ensure proper draw volume.


Storage Instructions

Freeze plasma. Maintain whole blood and buccal swab kit at room temperature or refrigerate.


Patient Preparation

Do not draw from an arm with a heparin lock or heparinized catheter.


Test Details


Methodology

See individual tests.


Footnotes

1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.Am J Clin Pathol. 1997 Jan; 107(1):105-110. 8980376
2. Reneke J, Etzell J, Leslie S, et al. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998; 109(6):754-757. 9620035
3. National Committee for Clinical Laboratory Standardization. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays; Approved Guideline. 5th ed. Villanova, Pa: NCCLS; 2008. Document H21-A5:28(5).
4. Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol. 1997; 107(6):681-683. 9169665
5. McGlasson DL, More L, Best HA, et al. Drawing specimens for coagulation testing: Is a second tube necessary? Clin Lab Sci. 1999; 12(3):137-139. 10539100

References

Alving BM. The antiphospholipid syndrome: Clinical presentation, diagnosis, and patient management. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. Philadelphia, Pa: WB Saunders Co; 2002:181-196.
Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing heritable thrombophilia. Br J Haem. 2010 Apr; 149(2):209-220. 20128794
Schafer AI, Levine MN, Konkle BA, Kearon C. Thrombotic disorders: Diagnosis and treatment. Hematology (Am Soc Hematol Educ Program). 2003; 520-539. 14633797
Triplett DA. Thrombophilia. In: McClatchey KD, ed. Clinical Laboratory Medicine. 2nd ed. Philadelphia, Pa: Lippincott Williams and Wilkins;2002:1033-1049.

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
385845 Thrombosis, Venous Congenital 015040 Antithrombin Activity % 27811-9
385845 Thrombosis, Venous Congenital 117705 Protein C-Functional % 27819-2
385845 Thrombosis, Venous Congenital 164519 Protein S, Free % 27821-8
385845 Thrombosis, Venous Congenital 511559 Factor V Leiden Mutation 21667-1
385845 Thrombosis, Venous Congenital 512258 Reviewed by: 56850-1
385845 Thrombosis, Venous Congenital 511218 Factor II, DNA Analysis 24476-4
385845 Thrombosis, Venous Congenital 512253 Reviewed by: 56850-1

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf